http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015218108-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3675c4129371bd9fda5228efc4faf364 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 |
filingDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1821c31191c40aec80b80164d2b78f76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e700c7cc143a4451ffcf29b210c5920 |
publicationDate | 2015-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2015218108-A |
titleOfInvention | Drug sustained release carrier |
abstract | As an adhesive, for example, it can be used for bone joining, and thereby exerts the effects of drugs such as antibiotics, anticancer agents, antiviral agents, etc. for a long time only in the vicinity of the bone joining part. Of a carrier for imparting sustained drug release, which is superior in biocompatibility. [MEANS FOR SOLVING PROBLEMS] A drug sustained release carrier obtained by polymerizing a monomer such as formula (1) that is a catechol derivative and a monomer that is a phenol derivative thereof, and a long-chain alkyl group in the drug sustained release carrier. A carrier into which is introduced. [Selection] Figure 1 |
priorityDate | 2014-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 52.